Skip to main content
Log in

Long-Chain Omega-3 Polyunsaturated Fatty Acids in the Blood of Children and Adolescents with Juvenile Bipolar Disorder

  • Original Article
  • Published:
Lipids

Abstract

Reduced long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been reported in adult patients suffering from depression and bipolar disorder (BD). LCn-3PUFA status has not previously been examined in children and adolescents with BD compared with healthy controls. Fifteen children and adolescents (9–18 years, M ± SD = 14.4 ± 3.48) diagnosed with juvenile bipolar disorder (JBD) and fifteen healthy age and sex-matched controls were assessed for dietary intake and fasting red blood cell (RBC) membrane concentrations of LCn-3PUFA. Fatty acid concentrations were compared between participants diagnosed with JBD and controls after controlling for dietary intake. RBC membrane concentrations of EPA and DHA were not significantly lower in participants diagnosed with JBD compared with healthy controls (M ± sem EPA = 3.37 ± 0.26 vs. 3.69 ± 0.27 µg/mL, P = 0.458; M ± sem DHA = 22.08 ± 2.23 vs. 24.61 ± 2.38 µg/mL, P = 0.528) after controlling for intake. Red blood cell DHA was negatively (r = −0.55; P = 0.044) related to clinician ratings of depression. Although lower RBC concentrations of LCn-3PUFA were explained by lower intakes in the current study, previous evidence has linked reduced LCn-3PUFA to the aetiology of BD. As RBC DHA was also negatively related to symptoms of depression, a randomised placebo-controlled study examining supplementation with LCn-3PUFA as an adjunct to standard pharmacotherapy appears warranted in this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

AA:

Arachidonic acid

BYI:

Beck Youth Inventories

CBCL:

Child Behaviour Checklist

C-GAS:

Global Assessment Scale for Children

CGI:

Clinical Global Impressions scale

DHA:

Docosahexaenoic acid

EPA:

Eicosapentaenoic acid

HAM-D:

Hamilton Depression Rating Scale

JBD:

Juvenile bipolar disorder

LCn-3PUFA:

Long-chain omega-3 polyunsaturated fatty acid

MDD:

Major depressive disorder

TMRS:

Tripartite Mood Rating Scale

YMRS:

Young Mania Rating Scale

References

  1. Geller B, Luby J (1997) Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 36(9):1168–1176

    Article  PubMed  CAS  Google Scholar 

  2. Reddy YC, Srinath S (2000) Juvenile bipolar disorder. Acta Psychiatr Scand 102(3):162–170

    Article  PubMed  CAS  Google Scholar 

  3. Lewinsohn PM, Klein DN, Seeley JR (2000) Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord 2(3):281–293

    Article  PubMed  CAS  Google Scholar 

  4. Youngstrom EA, Gracious BL, Danielson CK, Findling RL, Calabrese J (2003) Toward an integration of parent and clinician report on the young mania rating scale. J Affect Disord 77(2):179–190

    Article  PubMed  Google Scholar 

  5. Lewinsohn PM, Klein DN, Seeley JR (1995) Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 34(4):454–463

    Article  PubMed  CAS  Google Scholar 

  6. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM (1994) The national depressive and manic-depressive association (DMDA) survey of bipolar members. J Affect Disord 31(4):281–294

    Article  PubMed  CAS  Google Scholar 

  7. Noaghiul S, Hibbeln JR (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 160(12):2222–2227

    Article  PubMed  Google Scholar 

  8. Hibbeln JR (1998) Fish consumption and major depression. Lancet 351(9110):1213

    Article  PubMed  CAS  Google Scholar 

  9. Chiu CC, Huang SY, Su KP et al (2003) Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol 13(2):99–103

    Article  PubMed  CAS  Google Scholar 

  10. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1999) Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatr Res 85(3):275–291

    Article  CAS  Google Scholar 

  11. Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43(5):315–319

    Article  PubMed  CAS  Google Scholar 

  12. Sontrop J, Campbell MK (2006) Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 42(1):4–13

    Article  PubMed  CAS  Google Scholar 

  13. Sztern MI, Harris WS (1991) Short-term effects of fish oil on human plasma lipid levels. J Nutr Biochem 2(5):255–259

    Article  CAS  Google Scholar 

  14. Brown AJ, Pang E, Roberts DC (1991) Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 54(4):668–673

    PubMed  CAS  Google Scholar 

  15. World Medical Association (1964) Declaration of Helsinki. BMJ 313(7070):1448–1449

    Google Scholar 

  16. World Medical Association (1997) World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277(11):925–926

    Article  Google Scholar 

  17. NHMRC (2001) National statement on ethical conduct in research involving humans. National health and medical research council act 1992

  18. ICH (1996) Good clinical practice: consolidated guidance. In: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use E6, April, 1996

  19. Geller B, Williams M, Zimerman B, Frazier J (1996) Washington University in St. Louis kiddie schedule for affective disorders and schizophrenia (WASH-U-KSADS). Washington University, St Louis

  20. APA (2000) Diagnostic and statistical manual of mental disorders (text revised). 4th edn. American Psychiatric Association, Washington

  21. Findling RL, Gracious BL, McNamara NK et al (2001) Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord 3(4):202–210

    Article  PubMed  CAS  Google Scholar 

  22. Post RM, Luckenbaugh DA (2003) Unique design issues in clinical trials of patients with bipolar affective disorder. J Psychiatr Res 37(1):61–73

    Article  PubMed  Google Scholar 

  23. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H (1996) Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 38(1):35–46

    Article  PubMed  CAS  Google Scholar 

  24. Wirfalt E, Vessby B, Mattisson I, Gullberg B, Olsson H, Berglund G (2004) No relations between breast cancer risk and fatty acids of erythrocyte membranes in postmenopausal women of the Malmo Diet Cancer cohort (Sweden). Eur J Clin Nutr 58(5):761–770

    Article  PubMed  CAS  Google Scholar 

  25. Western J, McMillan J, Durrington D (1998) Differential access to higher education: the measurement of socioeconomic status, rurality and isolation. Department of Employment, Education, Training and Youth Affairs, Brisbane

  26. Crowe FL, Skeaff CM, Green TJ, Gray AR (2007) Serum phospholipid n-3 long-chain polyunsaturated fatty acids and physical and mental health in a population-based survey of New Zealand adolescents and adults. Am J Clin Nutr 86(5):1278–1285

    PubMed  CAS  Google Scholar 

  27. McMillan J, Jones FL (2000) The ANU3_2 scale: a revised occupational status scale for Australia. J Sociol 36(1):64–80

    Article  Google Scholar 

  28. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435

    Article  PubMed  CAS  Google Scholar 

  29. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23(2):56–62

    PubMed  CAS  Google Scholar 

  30. Guy W (1976) Clinical global impressions. New clinical drug evaluation unit (ECDEU). Assessment Manual for Psychopharmacology, pp 218–222

  31. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W (1997) Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatr Res 73(3):159–171

    Article  CAS  Google Scholar 

  32. Shaffer D, Gould MS, Brasic J et al (1983) A children’s global assessment scale (CGAS). Arch Gen Psychol 40(11):1228–1231

    CAS  Google Scholar 

  33. Achenbach TM, Rescorla LA (2001) Manual for the ASEBA school-age forms and profiles. VT University of Vermont, Research Centre and Children, Youth and Families, Burlington

  34. Beck J, Beck A, Jolly J (2001) Beck youth inventories of emotional and social impairment manual. TX Psychological Corporation, San Antonio

    Google Scholar 

  35. Hanstock TL, Clayton EH, Hunt SA, Hazell PL (2006) The tripartite mood rating scale (TMRS): a new self-report mood instrument for children and adolescents with bipolar. In: Biederman J (ed) NIMH paediatric bipolar conference, Chicago

  36. Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27(1):114–120

    PubMed  CAS  Google Scholar 

  37. Rodriguez-Palmero M, Lopez-Sabater MC, Castellote-Bargallo AI, De la Torre-Boronat MC, Rivero-Urgell M (1997) Comparison of two methods for the determination of fatty acid profiles in plasma and erythrocytes. J Chromatogr A 778(1–2):435–439

    Article  PubMed  CAS  Google Scholar 

  38. Garg ML, Blake RJ, Clayton EH et al (2007) Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II. Eur J Clin Nutr 61(11):1312–1317

    Article  PubMed  CAS  Google Scholar 

  39. Coakes SJ, Steed LG (2001) SPSS: analysis without anguish: Version 10.0 for windows. Wiley, Sydney

    Google Scholar 

  40. SAS Institute Inc (1997) SAS/STAT software: changes and enhancements through release 6.12. SAS Institute Inc, Carey

    Google Scholar 

  41. Littell RC, Henry PR, Ammerman CB (1998) Statistical analysis of repeated measures data using SAS procedures. J Anim Sci 76:1216–1231

    PubMed  CAS  Google Scholar 

  42. Horrobin DF, Bennett CN (1999) Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prost Leukotr Essent Fatty Acids 60(4):217–234

    Article  CAS  Google Scholar 

  43. Ross BM (2007) Omega-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism. Med Hypotheses 68(3):515–524

    Article  PubMed  CAS  Google Scholar 

  44. Edwards R, Peet M, Shay J, Horrobin D (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48(2–3):149–155

    Article  PubMed  CAS  Google Scholar 

  45. Huan M, Hamazaki K, Sun Y et al (2004) Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry 56(7):490–496

    Article  PubMed  CAS  Google Scholar 

  46. Colter AL, Cutler C, Meckling KA (2008) Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J 7(1):8

    Article  PubMed  CAS  Google Scholar 

  47. Eachus J, Williams M, Chan P et al (1996) Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ 312(7026):287–292

    PubMed  CAS  Google Scholar 

  48. Lehtinen V, Joukamaa M (1994) Epidemiology of depression: prevalence, risk factors and treatment situation. Acta Psychiatr Scand Suppl 377:7–10

    Article  PubMed  CAS  Google Scholar 

  49. Skapinakis P, Weich S, Lewis G, Singleton N, Araya R (2006) Socio-economic position and common mental disorders. Longitudinal study in the general population in the UK. Br J Psychiatry 189:109–117

    Article  PubMed  Google Scholar 

  50. Galobardes B, Morabia A, Bernstein MS (2001) Diet and socioeconomic position: does the use of different indicators matter? Int J Epidemiol 30(2):334–340

    Article  PubMed  CAS  Google Scholar 

  51. Barberger-Gateau P, Jutand MA, Letenneur L, Larrieu S, Tavernier B, Berr C (2005) Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur J Clin Nutr 59(7):817–825

    Article  PubMed  CAS  Google Scholar 

  52. Clayton EH, Hanstock TL, Garg ML, Hazell PL (2007) Long-chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents. Acta Neuropsych 19(2):92–103

    Article  Google Scholar 

  53. DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI (2006) One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res 47(1):172–180

    Article  PubMed  CAS  Google Scholar 

  54. Hamazaki T, Sawazaki S, Itomura M et al (1996) The effect of docosahexaenoic acid on aggression in young adults. J Clin Invest 97(4):1129–1133

    Article  PubMed  CAS  Google Scholar 

  55. Bjerve KS, Brubakk AM, Fougner KJ, Johnsen H, Midthjell K, Vik T (1993) Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipid fatty acids as markers of dietary omega 3-fatty acid intake. Am J Clin Nutr 57(5 Suppl):S801–S805

    Google Scholar 

  56. Lin PY, Su KP (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68(7):1056–1061

    Article  PubMed  CAS  Google Scholar 

  57. Ross BM, Seguin J, Sieswerda LE (2007) Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis 6(1):21

    Article  PubMed  CAS  Google Scholar 

  58. Harris WS (2007) Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 55(3):217–223

    Article  PubMed  CAS  Google Scholar 

  59. Chang MC, Grange E, Rabin O, Bell JM, Allen DD, Rapoport SI (1996) Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci Lett 220(3):171–174

    Article  PubMed  CAS  Google Scholar 

  60. Chang MC, Bell JM, Purdon AD, Chikhale EG, Grange E (1999) Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. Neurochem Res 24(3):399–406

    Article  PubMed  CAS  Google Scholar 

  61. Chang MC, Contreras MA, Rosenberger TA, Rintala JJ, Bell JM, Rapoport SI (2001) Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J Neurochem 77(3):796–803

    Article  PubMed  CAS  Google Scholar 

  62. Fehily AMA, Bowey OAM, Ellis FR, Meade BW, Dickerson JWT (1981) Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression. Neurochem Int 3(1):37–42

    Article  CAS  PubMed  Google Scholar 

  63. Keck PE, Freeman MP, McElroy SL et al (2002) A double-blind, placebo-controlled trial of eicosapentanoic acid in rapid cycling bipolar disorder. Bipolar Disord 4(Suppl 1):26–27

    Article  Google Scholar 

  64. Osher Y, Bersudsky Y, Belmaker RH (2005) Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry 66(6):726–729

    PubMed  CAS  Google Scholar 

  65. Frangou S, Lewis M, McCrone P (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188:46–50

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the expert technical assistance of Robert Blake for advice on LCn-3PUFA analysis and Melinda Phang for assistance in conducting analyses. We also thank staff from the Hunter Area Pathology Service for assistance with blood collection and Dr Trent Watson for advice on the preparation of this manuscript. This study was conducted without dedicated external funding. This study was supported from in-kind donations from the Nutraceuticals Research Group and Hunter New England Area Health Service. Dr Clayton, Dr Hanstock, Mr Hirneth, Dr Kable, Professor Garg and Professor Hazell have previously received in-kind donations of omega-3 capsules from NuMega Ingredients Pty Ltd. The authors do not have any other financial interests or potential conflicts of interest in connection with this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward H. Clayton.

About this article

Cite this article

Clayton, E.H., Hanstock, T.L., Hirneth, S.J. et al. Long-Chain Omega-3 Polyunsaturated Fatty Acids in the Blood of Children and Adolescents with Juvenile Bipolar Disorder. Lipids 43, 1031–1038 (2008). https://doi.org/10.1007/s11745-008-3224-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11745-008-3224-z

Keywords

Navigation